- Home
- AEYE vs NVCT Comparison
AEYE vs NVCT Comparison
Compare AEYE & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEYE | NVCT |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9M | 167.0M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | AEYE | NVCT |
|---|---|---|
| Price | $12.30 | $6.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $22.00 | $15.33 |
| AVG Volume (30 Days) | ★ 109.5K | 90.0K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,540,000.00 | N/A |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $14.79 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.57 | N/A |
| 52 Week Low | $8.91 | $4.44 |
| 52 Week High | $28.50 | $11.52 |
Technical Indicators
Market Signals| Indicator | AEYE | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 54.35 |
| Support Level | $11.04 | $5.85 |
| Resistance Level | $12.92 | $6.21 |
| Average True Range (ATR) | 0.73 | 0.28 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 43.88 | 70.91 |
Price Performance
Historical ComparisonAbout AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.